MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation DIO Ratio 2011-2026 | DHR
Annual DIO Ratio Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.6 | 92.9 | 99.2 | 96.6 | 96.5 | 72.9 | 75 | 79.4 | 82.6 | 82.7 | 78 | 70.6 | 71.1 | 74.8 | 82.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 99.2 | 70.6 | 82.8 |
Quarterly DIO Ratio Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99.5 | - | - | - | - | 95.3 | 89.3 | - | - | 44.8 | 88.6 | - | - | - | 39.1 | - | - | - | 39.9 | - | - | - | 40.9 | - | 84.4 | 80 | 84.7 | - | 84.5 | 83.8 | 85.2 | - | 103 | 82.5 | 79.5 | - | 73.1 | 71.3 | 73.6 | - | 72.5 | 72.6 | 77.5 | - | 77.4 | 75.3 | 78.8 | - | 71.8 | 94.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 39.1 | 76.6 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Bioventus
BVS
|
177 | $ 9.25 | -0.11 % | $ 616 M |  USA |
 |
DarioHealth Corp.
DRIO
|
171 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
60.9 | - | - | $ 19.8 B | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
IDEXX Laboratories
IDXX
|
84.3 | $ 566.57 | -1.17 % | $ 45.6 B | USA |
 |
Illumina
ILMN
|
137 | $ 121.35 | -2.45 % | $ 19.3 B | USA |
 |
Trinity Biotech plc
TRIB
|
212 | $ 0.62 | 1.06 % | $ 61.9 M |  Irlanda |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
304 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
OPKO Health
OPK
|
45.2 | $ 1.14 | -2.44 % | $ 791 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 160.77 | -2.64 % | $ 7.97 B | USA |
 |
Organovo Holdings
ONVO
|
371 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
459 | - | -16.95 % | $ 1.54 M | USA |
 |
Waters Corporation
WAT
|
528 | $ 295.27 | -1.76 % | $ 17.6 B | USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
405 | $ 4.79 | 6.32 % | $ 2.57 M | USA |
 |
PerkinElmer
PKI
|
87.6 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
126 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
26.2 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
Soleno Therapeutics
SLNO
|
1.02 K | $ 31.12 | -2.23 % | $ 1.58 B | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B |  Niderland |
 |
Thermo Fisher Scientific
TMO
|
86.5 | $ 482.91 | -1.22 % | $ 182 B | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Senseonics Holdings
SENS
|
104 | $ 6.53 | -0.53 % | $ 272 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.9 | $ 265.93 | -0.91 % | $ 22.1 B | USA |
 |
NeoGenomics
NEO
|
24.4 | $ 7.58 | -2.32 % | $ 971 M | USA |
 |
Precipio
PRPO
|
21.7 | $ 26.54 | -2.43 % | $ 34.4 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 17.22 | -1.43 % | $ 918 M | USA |